Clinical Trial Update: A Study of MEHD7945A and Cobimetinib in Patients With Locally Advanced or Metastatic Cancers With Mutant KRAS [Phase 1]

View source ↗

Summary

This is a completed Phase 1 clinical trial evaluating the combination of MEHD7945A and cobimetinib in patients with locally advanced or metastatic cancers harbo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neoplasms

Drugs mentioned

• Cobimetinib (cobimetinib)
• MEHD7945A (MEHD7945A)

Snippet

Sponsor: Genentech, Inc. | Conditions: Neoplasms | Phase 1 | Status: COMPLETED